Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | PDE4A | P27815 | 1/20 | 0.71 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.71 |
| ▸ | AKT1 | P31749 | 6/20 | 0.69 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.62 |
| ▸ | PHLPP1 | O60346 | 2/20 | 0.62 |
| ▸ | ILK | Q13418 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | TTPA | P49638 | 2/20 | 0.59 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.58 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390266 | 1.00 | MEN1 (0.71) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL708743 | 0.89 | GSTO1 (0.74) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL29959827 | 0.89 | AKT1 (0.64) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL4259671 | 0.87 | AKT1 (0.91) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL3241425 | 0.87 | PSEN1 (0.72) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL20635554 | 0.86 | AKT1 (0.60) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL14359795 | 0.86 | AKT1 (0.60) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL25118491 | 0.85 | MEN1 (0.72) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL708027 | 0.85 | MEN1 (0.72) | MEN1KMT2APDE4APDE3AAKT1 | |
| SCHEMBL8894988 | 0.85 | GSTO1 (0.71) | MEN1KMT2APDE4APDE3AAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116407543-A | EPA-EE nano lipid composition, preparation method and application thereof | 中国科学院上海药物研究所 | 2023-07-11 | — | — | CN | claimed |
| CN-110669255-A | Stabilizer compositions containing substituted chroman compounds and methods of use thereof | 塞特克技术公司 | 2020-01-10 | — | — | CN | claimed |
| US-9801913-B2 | Barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2017-10-31 | — | — | US | claimed |
| US-8821568-B2 | Implant modified with non-hydroxylated vitamin D precursors | NUMAT BIOMEDICAL S.L. (ES) | 2014-09-02 | — | — | US | claimed |
| US-8795703-B2 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2014-08-05 | — | — | US | claimed |
| US-8367099-B2 | Perforated fatty acid films | ATRIUM MEDICAL CORPORATION (US) | 2013-02-05 | — | — | US | claimed |
| US-20130017234-A1 | IMPLANT MODIFIED WITH NON-HYDROXYLATED VITAMIN D PRECURSORS | NUMAT BIOMEDICAL S.L. (ES) | 2013-01-17 | — | — | US | claimed |
| WO-2010104786-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | ATRIUM MEDICAL CORPORATION (US) | 2010-09-16 | — | — | WO | claimed |
| US-20100233231-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | ATRIUM MEDICAL CORPORATION | 2010-09-16 | — | — | US | claimed |
| EP-2086605-A2 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | Atrium Medical Corporation (US) | 2009-08-12 | — | — | EP | claimed |
| WO-2008039308-A2 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1812022-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | Atrium Medical Corporation (US) | 2007-08-01 | — | — | EP | claimed |
| US-20070071798-A1 | Perforated bioabsorbable oil film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2007-03-29 | — | — | US | claimed |
| US-20060088596-A1 | Solubilizing a drug for use in a coating | ATRIUM MEDICAL CORPORATION (US) | 2006-04-27 | — | — | US | claimed |
| US-20060083768-A1 | Method of thickening a coating using a drug | ATRIUM MEDICAL CORPORATION (US) | 2006-04-20 | — | — | US | claimed |
| WO-2006036984-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| WO-2006036970-A2 | METHOD OF THICKENING A COATING USING A DRUG | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| WO-2006036967-A1 | SOLUBILIZING A DRUG FOR USE IN A COATING | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| US-20060067983-A1 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | claimed |
| US-6977269-B1 | Method of improving animal tissue quality | PIONEER HI-BRED INTERNATIONAL, INC (US) | 2005-12-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233231-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | LIPA, CETP, CPT2 | MEN1 2327/4885KMT2A 1477/4885PDE4A 1809/4885 |
| US-20060083768-A1 | Method of thickening a coating using a drug | ABCB1, SLC10A2, ABCB11 | MEN1 700/4885KMT2A 2668/4885PDE4A 1121/4885 |
| US-20060088596-A1 | Solubilizing a drug for use in a coating | ABCB11, ABCB1, SLC10A2 | MEN1 1118/4885KMT2A 3563/4885PDE4A 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.